Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
The current price of Pfizer Inc in the market is 44,94 лв., with a 24-hour trading volume of 2,27B лв.. The asset's market cap is 255,54B лв., after moving 2.76% in the last day.
Tokenized Pfizer Inc is trading at 45,14 лв., with a tokenized market cap of 7,51M лв. and a 24-hour trading volume of 62,16 лв.. The tokenized asset has moved -0.01% in the past 24 hours.